Microcapsules containing oil drag-reducing polymer particles were prepared by melting-scattering and condensing of polyethylene wax,in-situ polymerization of urea and formaldehyde,and interfacial polymerization of sty...Microcapsules containing oil drag-reducing polymer particles were prepared by melting-scattering and condensing of polyethylene wax,in-situ polymerization of urea and formaldehyde,and interfacial polymerization of styrene respectively.The related processes were studied by a molecular dynamics simulation method,and molecular design of microcapsule isolation agent was carried out on the basis of the simulation.The technologies for preparing microencapsulated oil drag-reducing polymer particles were compared and the circulation drag reducing efficiency of the microencapsulated polymer particles was evaluated based on the characterization results and their dissolution properties.Molecular design of a microcapsule isolation agent suggests that a-olefin polymer particles can be stably dispersed in water by using long-chain alkyl sodium salt surfactant which can prevent the agglomeration ofα-olefin polymer particles.The results of simulation of the adsorption process shows that the amount of alkyl sodium salt surfactant can directly affect the stability of microencapsulatedα-olefin polymer particles, and there must be a minimum critical amount of it.After characterization of the morphology by Scanning Electron Microscopy（SEM） and comparison of the static pressure stability,especially the conditions of reaction and technological control of microcapsules with different shell materials,microencapsulation of a-olefin polymer particles with poly-（urea-formaldehyde） as shell material was selected as the optimum scheme,because it can react under mild conditions and its technological process can be controlled in a large range.The relationship of drag reducing rate and dissolving time of microcapsules showed that the formation of microcapsules did not affect the maximum drag reducing rate,and the drag reducing rate of each sample can reach about 35%along with the dissolving time,i.e.microencapsulation did not affect the drag reducing property ofα-olefin polymer.展开更多
The solid form of drugs plays a central role in optimizing the physicochemical properties of drugs,and new solid forms will provide more options to achieve the desirable pharmaceutical profiles of drugs.Recently,certa...The solid form of drugs plays a central role in optimizing the physicochemical properties of drugs,and new solid forms will provide more options to achieve the desirable pharmaceutical profiles of drugs.Recently,certain drugs have been found to form crystalline inclusion complexes（ICs） with multiple types of linear polymers,representing a new subcategory of pharmaceutical solids.In this study,we used diflunisal（DIF） as the model drug host and extended the guest of drug/polymer ICs from homopolymers to block copolymers of poly（ethylene glycol）（PEG） and poly（s-caprolactone）（PCL）.The block length in the guest copolymers showed a significant influence on the formation,thermal stability and dissolution behavior of the DIF ICs.Though the PEG block could hardly be included alone,it could indeed be included in the DIF ICs when the PCL block was long enough.The increase of the PCL block length produced IC crystals with improved thermal stability.The dissolution profiles of DIF/block copolymer ICs exhibited gradually decreased aqueous solubility and dissolution rate with the increasing PCL block length.These results demonstrate the possibility of using drug/polymer ICs to modulate the desired pharmaceutical profiles of drugs in a predictable and controllable manner.展开更多
文摘Microcapsules containing oil drag-reducing polymer particles were prepared by melting-scattering and condensing of polyethylene wax,in-situ polymerization of urea and formaldehyde,and interfacial polymerization of styrene respectively.The related processes were studied by a molecular dynamics simulation method,and molecular design of microcapsule isolation agent was carried out on the basis of the simulation.The technologies for preparing microencapsulated oil drag-reducing polymer particles were compared and the circulation drag reducing efficiency of the microencapsulated polymer particles was evaluated based on the characterization results and their dissolution properties.Molecular design of a microcapsule isolation agent suggests that a-olefin polymer particles can be stably dispersed in water by using long-chain alkyl sodium salt surfactant which can prevent the agglomeration ofα-olefin polymer particles.The results of simulation of the adsorption process shows that the amount of alkyl sodium salt surfactant can directly affect the stability of microencapsulatedα-olefin polymer particles, and there must be a minimum critical amount of it.After characterization of the morphology by Scanning Electron Microscopy（SEM） and comparison of the static pressure stability,especially the conditions of reaction and technological control of microcapsules with different shell materials,microencapsulation of a-olefin polymer particles with poly-（urea-formaldehyde） as shell material was selected as the optimum scheme,because it can react under mild conditions and its technological process can be controlled in a large range.The relationship of drag reducing rate and dissolving time of microcapsules showed that the formation of microcapsules did not affect the maximum drag reducing rate,and the drag reducing rate of each sample can reach about 35%along with the dissolving time,i.e.microencapsulation did not affect the drag reducing property ofα-olefin polymer.
基金financially supported by the National Natural Science Foundation of China(Nos.21434008,21374054)National Basic Research Program of China(973 Program,No.2014CB932202)
文摘The solid form of drugs plays a central role in optimizing the physicochemical properties of drugs,and new solid forms will provide more options to achieve the desirable pharmaceutical profiles of drugs.Recently,certain drugs have been found to form crystalline inclusion complexes（ICs） with multiple types of linear polymers,representing a new subcategory of pharmaceutical solids.In this study,we used diflunisal（DIF） as the model drug host and extended the guest of drug/polymer ICs from homopolymers to block copolymers of poly（ethylene glycol）（PEG） and poly（s-caprolactone）（PCL）.The block length in the guest copolymers showed a significant influence on the formation,thermal stability and dissolution behavior of the DIF ICs.Though the PEG block could hardly be included alone,it could indeed be included in the DIF ICs when the PCL block was long enough.The increase of the PCL block length produced IC crystals with improved thermal stability.The dissolution profiles of DIF/block copolymer ICs exhibited gradually decreased aqueous solubility and dissolution rate with the increasing PCL block length.These results demonstrate the possibility of using drug/polymer ICs to modulate the desired pharmaceutical profiles of drugs in a predictable and controllable manner.
